Tyra Biosciences, Inc
Clinical trials sponsored by Tyra Biosciences, Inc, explained in plain language.
-
New pill could shrink rare bladder tumors without surgery
Disease control Recruiting nowThis study tests a new drug called dabogratinib (TYRA-300) in 230 adults with a rare, low-grade cancer in the upper urinary tract. The goal is to see if the drug can make tumors disappear completely within 6 months. Participants take the drug by mouth and are monitored for safety…
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 17, 2026 01:04 UTC
-
New drug targets Hard-to-Treat cancers in first human study
Disease control Recruiting nowThis early-stage study tests a new oral drug, TYRA-430, in people with advanced liver cancer or other solid tumors that have specific genetic changes (FGF/FGFR pathway). The main goals are to find a safe dose and check for side effects. About 100 adults will take part, and the st…
Phase: PHASE1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 17, 2026 01:03 UTC
-
New pill targets bladder Cancer's genetic weakness
Disease control Recruiting nowThis study tests a new drug called TYRA-300 in people with a low-grade, intermediate-risk bladder cancer that has not invaded the muscle. The drug targets tumors with specific changes in the FGFR3 gene. About 90 adults will take the drug to see if it shrinks tumors and delays can…
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug could boost growth in kids with dwarfism
Disease control Recruiting nowThis study tests a new medicine called TYRA-300 in children aged 3 to 10 with achondroplasia (the most common form of dwarfism). The goal is to see if it is safe and can help them grow taller. About 92 children will take part, and the study will look at growth speed and side effe…
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 12, 2026 13:43 UTC